Literature DB >> 17558488

Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot.

K Riesbeck1, B Hammas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17558488     DOI： 10.1007/s10096-007-0329-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   5.103


× No keyword cloud information.
  10 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes.

Authors:  S Y Sung; J V McDowell; R T Marconi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

3.  Lyme disease--United States, 2001-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-05-07       Impact factor: 17.586

4.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

Review 5.  The burgeoning molecular genetics of the Lyme disease spirochaete.

Authors:  Patricia A Rosa; Kit Tilly; Philip E Stewart
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

6.  Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.

Authors:  M B Lawrenz; J M Hardham; R T Owens; J Nowakowski; A C Steere; G P Wormser; S J Norris
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.

Authors:  Antonella Marangoni; Vittorio Sambri; Silvia Accardo; Francesca Cavrini; Valeria Mondardini; Alessandra Moroni; Elisa Storni; Roberto Cevenini
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 8.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

9.  Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease.

Authors:  S J Padula; F Dias; A Sampieri; R B Craven; R W Ryan
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  C6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis.

Authors:  Mario T Philipp; Adriana R Marques; Paul T Fawcett; Leonard G Dally; Dale S Martin
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
  10 in total
  2 in total

1.  Study of a Cohort of 1,886 Persons To Determine Changes in Antibody Reactivity to Borrelia burgdorferi 3 Months after a Tick Bite.

Authors:  Ram B Dessau; Linda Fryland; Peter Wilhelmsson; Christina Ekerfelt; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  Clin Vaccine Immunol       Date:  2015-05-20

Review 2.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.